MX2023000628A - Inserto ocular que contiene un glucocorticoide. - Google Patents
Inserto ocular que contiene un glucocorticoide.Info
- Publication number
- MX2023000628A MX2023000628A MX2023000628A MX2023000628A MX2023000628A MX 2023000628 A MX2023000628 A MX 2023000628A MX 2023000628 A MX2023000628 A MX 2023000628A MX 2023000628 A MX2023000628 A MX 2023000628A MX 2023000628 A MX2023000628 A MX 2023000628A
- Authority
- MX
- Mexico
- Prior art keywords
- glucocorticoid
- insert containing
- ocular insert
- intracanalicular
- hydrogel
- Prior art date
Links
- 239000003862 glucocorticoid Substances 0.000 title abstract 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052646P | 2020-07-16 | 2020-07-16 | |
| US202063124176P | 2020-12-11 | 2020-12-11 | |
| US202163181720P | 2021-04-29 | 2021-04-29 | |
| PCT/US2021/041761 WO2022015940A1 (fr) | 2020-07-16 | 2021-07-15 | Insert oculaire contenant un glucocorticoïde |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023000628A true MX2023000628A (es) | 2023-02-27 |
Family
ID=77300995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023000628A MX2023000628A (es) | 2020-07-16 | 2021-07-15 | Inserto ocular que contiene un glucocorticoide. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4181930A1 (fr) |
| JP (1) | JP2023534952A (fr) |
| KR (1) | KR20230041708A (fr) |
| CN (1) | CN116133664A (fr) |
| AU (1) | AU2021309965A1 (fr) |
| BR (1) | BR112023000669A2 (fr) |
| CA (1) | CA3174217A1 (fr) |
| IL (1) | IL299769A (fr) |
| MX (1) | MX2023000628A (fr) |
| WO (1) | WO2022015940A1 (fr) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008011136A2 (fr) | 2006-07-20 | 2008-01-24 | Sicor Inc. | Procédé de préparation d'un ingrédient pharmaceutique actif stérile solide |
| EP2156823A1 (fr) | 2008-08-14 | 2010-02-24 | Pharmatex Italia Srl | Processus de préparation de composés pharmaceutiques poudrés stériles sous la forme de micro et nano particules |
| JP5890182B2 (ja) * | 2009-02-12 | 2016-03-22 | インセプト エルエルシー | ヒドロゲルプラグによる薬物送達 |
| EP4279064A3 (fr) | 2015-05-12 | 2024-02-28 | Incept, LLC | Administration de médicament à partir d'hydrogels |
| EP3515406A1 (fr) * | 2016-09-23 | 2019-07-31 | Incept, LLC | Dépôts pour l'administration de médicament en intracaméral |
-
2021
- 2021-07-15 EP EP21752805.8A patent/EP4181930A1/fr active Pending
- 2021-07-15 WO PCT/US2021/041761 patent/WO2022015940A1/fr unknown
- 2021-07-15 IL IL299769A patent/IL299769A/en unknown
- 2021-07-15 MX MX2023000628A patent/MX2023000628A/es unknown
- 2021-07-15 CA CA3174217A patent/CA3174217A1/fr active Pending
- 2021-07-15 CN CN202180060084.6A patent/CN116133664A/zh active Pending
- 2021-07-15 KR KR1020237002637A patent/KR20230041708A/ko unknown
- 2021-07-15 AU AU2021309965A patent/AU2021309965A1/en active Pending
- 2021-07-15 JP JP2023502835A patent/JP2023534952A/ja active Pending
- 2021-07-15 BR BR112023000669A patent/BR112023000669A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230041708A (ko) | 2023-03-24 |
| IL299769A (en) | 2023-03-01 |
| CN116133664A (zh) | 2023-05-16 |
| EP4181930A1 (fr) | 2023-05-24 |
| CA3174217A1 (fr) | 2022-01-20 |
| AU2021309965A1 (en) | 2023-02-23 |
| JP2023534952A (ja) | 2023-08-15 |
| WO2022015940A1 (fr) | 2022-01-20 |
| BR112023000669A2 (pt) | 2023-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020002381A (es) | Implantes intraoculares que contienen prostamida y metodos para su uso. | |
| BR112015022161A2 (pt) | implante intraocular contendo prostamida | |
| UY30058A1 (es) | (indazol-5-il)-piracinas y (1,3-dihidro-indol-2-on)-piracinas para el tratamiento de enfermedades y afecciones mediadas por la rho quinasa | |
| CL2022002606A1 (es) | Implante ocular que contiene un inhibidor de la tirosina cinasa | |
| CY1115912T1 (el) | Μειωση ενδοφθαλμιας πιεσης με ενδοθαλαμικα εμφυτευματα βηματοπροστης | |
| ECSP12012037A (es) | Composiciones oftálmicas no irritantes de iodopovidona | |
| MY197845A (en) | Pharmaceutical composition | |
| AR088585A1 (es) | Un medicamento para tratar la enfermedad del ojo anterior | |
| MX2020005240A (es) | Sistemas y metodos para cirugia laser ocular y tratamientos terapeuticos. | |
| CL2017001301A1 (es) | Composiciones oftálmicas estabilizadas de omega 3 | |
| CL2020001183A1 (es) | Implantes de liberación sostenida para reducir la presión intraocular con duración prolongada del efecto. | |
| WO2014145666A3 (fr) | Traitements de matrices extracellulaires de l'œil | |
| NZ746468A (en) | Methods of treating ocular conditions | |
| MX2020003534A (es) | Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares. | |
| CL2012002612A1 (es) | Compuestos derivados de benciloxicicloalquiladenosina, como agonistas selectivos de receptores de adenosina a1; composicion farmaceutica oftalmica; y su uso para el tratamiento de una afeccion seleccionada entre presion intraocular elevada, hipertension ocular o glaucoma. | |
| MX2023000628A (es) | Inserto ocular que contiene un glucocorticoide. | |
| MX2021013048A (es) | Insertos de hidrogel intracanalicular para el suministro de anestesicos. | |
| DOP2021000098A (es) | Asesor de procedimiento corneal topográfico inteligente | |
| SI1937281T1 (sl) | Modulacija trpv izraĺ˝enih nivojev | |
| CL2011001812A1 (es) | Uso de deferiprona para prevenir yotratar un trastorno ocular relacionado con hierro seleccionado de : degeneracion macular relacionada con la edad, glaucoma, cataratas, retinopatía diabetica, degeneración hereditaria de la retina, desprendiimiento de la retina, retinopatía isquémica, entre otras. | |
| GB2525994A (en) | Antimicrobial ophthalmic contact lenses | |
| MX2017004809A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
| MY193529A (en) | Ophthalmologic pharmaceutical composition | |
| UY33562A (es) | Agonistas de receptores de bradicinina y su utilización para el tratamiento de la hipertensión ocular y el glaucoma | |
| MX2018004779A (es) | Uso terapeutico de una solucion oftalmica acuosa esteril. |